Cutler Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$3K Buy
+200
New +$3K ﹤0.01% 759
2023
Q4
Hold
0
1855
2023
Q3
Sell
-8,080
Closed -$379K 1896
2023
Q2
$379K Buy
8,080
+180
+2% +$8.44K 0.05% 237
2023
Q1
$331K Sell
7,900
-300
-4% -$12.6K 0.03% 261
2022
Q4
$312K Hold
8,200
0.03% 350
2022
Q3
$321K Sell
8,200
-170
-2% -$6.66K 0.02% 366
2022
Q2
$270K Sell
8,370
-2,065
-20% -$66.6K 0.02% 386
2022
Q1
$345K Buy
10,435
+2,835
+37% +$93.7K 0.02% 427
2021
Q4
$323K Buy
7,600
+720
+10% +$30.6K 0.01% 524
2021
Q3
$304K Buy
6,880
+5,040
+274% +$223K 0.01% 560
2021
Q2
$104K Sell
1,840
-2,086
-53% -$118K ﹤0.01% 978
2021
Q1
$293K Buy
3,926
+3,002
+325% +$224K 0.01% 542
2020
Q4
$79K Buy
+924
New +$79K ﹤0.01% 859
2020
Q3
Sell
-1,100
Closed -$45K 2191
2020
Q2
$45K Buy
+1,100
New +$45K ﹤0.01% 874
2020
Q1
Sell
-3,671
Closed -$265K 1960
2019
Q4
$265K Buy
+3,671
New +$265K 0.02% 438
2019
Q3
Hold
0
2028
2019
Q2
Hold
0
2105
2019
Q1
Hold
0
2086
2018
Q4
Hold
0
2092
2018
Q3
Sell
-1,500
Closed -$234K 2095
2018
Q2
$234K Buy
1,500
+407
+37% +$63.5K 0.02% 484
2018
Q1
$176K Buy
1,093
+3
+0.3% +$483 0.02% 572
2017
Q4
$179K Sell
1,090
-1,421
-57% -$233K 0.01% 660
2017
Q3
$156K Sell
2,511
-29,031
-92% -$1.8M 0.01% 836
2017
Q2
$2.51M Buy
31,542
+31,022
+5,966% +$2.47M 0.09% 136
2017
Q1
$36K Sell
520
-15,360
-97% -$1.06M ﹤0.01% 1634
2016
Q4
$810K Sell
15,880
-543
-3% -$27.7K 0.03% 341
2016
Q3
$756K Sell
16,423
-3,245
-16% -$149K 0.03% 296
2016
Q2
$592K Buy
19,668
+17,368
+755% +$523K 0.03% 330
2016
Q1
$73K Buy
2,300
+300
+15% +$9.52K ﹤0.01% 1092
2015
Q4
$116K Buy
+2,000
New +$116K 0.01% 963